Perrigo’s Next CEO Has Long OTC Brands History
Lockwood-Taylor Moves From Bayer As Perrigo Awaits Decision On OTC Oral Contraceptive
Patrick Lockwood-Taylor starts as president/CEO on 30 June, succeeding Murray Kessler as Perrigo awaits FDA decision on subsidiary HRA’s proposal for first US OTC sales of daily oral contraceptive. He’s moving from president of Bayer AG’s US business and regional president, consumer health North America.
